Insider Transactions in Q4 2021 at Biogen Inc. (BIIB)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 03
2021
|
Robin Kramer Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
100
-4.19%
|
$22,300
$223.92 P/Share
|
|
Dec 03
2021
|
Robin Kramer Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
339
+12.61%
|
$75,597
$223.92 P/Share
|
|
Dec 02
2021
|
Rachid Izzar Head of Global Product Strat. |
SELL
Payment of exercise price or tax liability
|
Direct |
165
-12.98%
|
$37,620
$228.52 P/Share
|
|
Dec 02
2021
|
Rachid Izzar Head of Global Product Strat. |
BUY
Exercise of conversion of derivative security
|
Direct |
372
+22.64%
|
$84,816
$228.52 P/Share
|